Back
Tarsus Pharmaceuticals 10K Form
Buy
84
TARS
Tarsus Pharmaceuticals
Last Price:
44.62
Seasonality Move:
37.14%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TARS News And Ratings
See the #1 stock for the next 7 days that we like better than TARS
TARS Financial Statistics
Sales & Book Value
Annual Sales: | $17.45M |
---|---|
Cash Flow: | $-15.44M |
Price / Cash Flow: | 0 |
Annual Sales: | $6.63 |
Price / Book: | 6.62 |
Profitability
EPS (TTM): | -4.48000 |
---|---|
Net Income (TTM): | $-150.07M |
Gross Margin: | $15.85M |
Return on Equity: | -69.1% |
Return on Assets: | -51.79% |
Tarsus Pharmaceuticals Earnings Forecast
Key Tarsus Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 4 years for TARS is 90.87%.
- The Selling, General & Administrative Expenses for TARS have been equal to 623.03% of Gross Profit Margin.
- The Research & Development expenses have been 288.37% of Revenue.
- The Interest Expense is -2.37% of Operating Income.
- The Net Earning history of TARS is -778.89% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 1 years.
Tarsus Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | TARS |
Website: | tarsusrx.com |
Debt
Debt-to-Equity Ratio: | 0.28 |
---|---|
Current Ratio: | 7.03 |
Quick Ratio: | 6.87 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
TARS Technical Analysis vs Fundamental Analysis
Buy
84
Tarsus Pharmaceuticals (TARS)
is a Buy
Is Tarsus Pharmaceuticals a Buy or a Sell?
-
Tarsus Pharmaceuticals stock is rated a Buy
The current Tarsus Pharmaceuticals [TARS] share price is $43.87. The Score for TARS is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.